The Study of Epidemiology, Clinicopathology and Current Management in Patients of Colorectal Malignancies in Northern India
Published: 2023-07-28
Page: 81-91
Issue: 2023 - Volume 6 [Issue 1]
Shalini Goswami *
Department of Surgery, Jawaharlal Nehru Medical College, Aligarh, India.
Rahul Kumar Giri
Department of Surgery, Shyam Shah Medical College, Rewa, India.
Afzal Anees
Department of Surgery, Jawaharlal Nehru Medical College, Aligarh, India.
Yaqoob Hassan
Department of Surgery, Jawaharlal Nehru Medical College, Aligarh, India.
*Author to whom correspondence should be addressed.
Abstract
Background: Colorectal malignancy is the third most common malignancy worldwide and the incidence in India is showing an increasing trend. Rapidly increasing incidence rates could result from epidemiological factors including age , race, diet, environmental exposures, and acquisition of modern lifestyle. This study was conducted to describe the epidemiological trends, clinicopathologic characteristics and management of CRC in our settings.
Methods: This prospective study was carried out from November 2020 to November 2022 in the Department of Surgery, at Jawaharlal Nehru Medical College, Aligarh. All histologically confirmed cases of colorectal cancer were included. The data was collected and analysed using IBM SPSS Statistics for windows, version 25.
Results: A total of 54 patients with colorectal malignancy were in the study. Males outnumbered females with a Ratio of 1.24.Most of the patients were below 40years of age (42.8%) and the mean age was 45.27±14.208 years. 32 patients (57.1%) were non-vegetarian and 24 patients (42.8%) were vegetarian (P value >0.05). 19.6% of patients had a smoking addiction, 5.3% used tobacco and 3.5% of patients were alcohol drinkers (P value <0.0001). 3 patients(5.3%) had a positive family history of carcinoma or polyposis in their first-degree or second-degree relatives(P value <0.0001). Bleeding per rectum was the commonest presentation (33.9% followed by pain abdomen (26.7%). The highest number of lesion was seen in the rectum alone (46.4%), followed by ascending colon alone (19.6%).On endoscopy, 29(51.7%) patients had circumferential annular growth, 21(37.5%) patients had exophytic mass, 3(5.3%) patients had polyposis masses and 3(5.3%) ulcero-infiltrating mass. Non-mucin-secreting adenocarcinoma was the commonest pathological finding (62.5%), followed by mucin-secreting Adenocarcinoma (30.3% ) and signet ring cell carcinoma (7.1%). 32 (57.1%) patients had well-differentiated lesions, 17(30.3%) had moderately differentiated lesions and 7(12.5%) patients had poorly differentiated lesions. The majority (60.7%) of the participants have lymph node involvement. 51 patients (91.1%) underwent surgeries and 5 patients (8.9%) were given neoadjuvant chemo-radiation therapy. There was no mortality during the study period.
Conclusion: Colorectal malignancies are common in our settings and shows a trend towards younger age groups. We recommend screening high-risk groups for early diagnosis and better management.
Keywords: Colorectal, cancer, colon, rectum, chemotherapy, young age
How to Cite
References
Agarwal R, Kumar B, Jayadev M, Raghav D, Singh A. CoReCG: A comprehensive database of genes associated with colon-rectal cancer. Database. 2016 Jan 1;2016.
Deo SV, Kumar S, Bhoriwal S, Shukla NK, Sharma A, Thulkar S, et al. Colorectal Cancers in Low-and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India. JCO Global Oncology. 2021 Jul;7:1110-5.
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020 Oct 17;396(10258):1204-22.
Barresi V. Colorectal Cancer: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. 2021 Dec 8;9(12):1858.
Siegel, RL, Wagle, NS, Cercek, A, Smith, RA, Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233- 254.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14 (2):89–103.
Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, Lim YC, Kibria KK, Mohiuddin AK, Ming LC, Goh KW. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers. 2022 Mar 29;14(7):1732.
Macrae FA. Colorectal cancer: Epidemiology, risk factors, and protective factors. Uptodate com [ažurirano 9. lipnja 2017; 2016 Jan.
Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 2021 Jan;13(9):2025.
Fegiz G, Barillari P, Ramacciato G, De Angelis R, Gozzo P, Indinnimeo M, Valabrega S. Right colon cancer: Long-term results after curative surgery and prognostic significance of duration of symptoms. Journal of surgical oncology. 1989 Aug;41(4):250-5.
Luo C, Cen S, Ding G, Wu W. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer communications. 2019 Dec;39(1):1-3.
Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical chemistry. 2001 Apr 1;47(4):624-30.
Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma–carcinoma sequence. British Journal of Surgery. 2002 Jul;89(7):845-60.
Elzouki AN, Habel S, Alsoaeiti S, Abosedra A, Khan F. Epidemiology and clinical findings of colorectal carcinoma in two tertiary care hospitals in Benghazi, Libya. Avicenna journal of medicine. 2014 Oct;4(04):94-8.
Poornakala S, Prema NS. A study of morphological prognostic factors in colorectal cancer and survival analysis. Indian Journal of Pathology and Microbiology. 2019 Jan 1;62(1):36.
Ayyub MI, Al-Radi AO, Khazeindar AM, Nagi AH, Maniyar IA. Clinicopathological trends in colorectal cancer in a tertiary care hospital. Saudi medical journal. 2002 Feb 1;23(2):160-3.
Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, kerin M. Neoadjuvant radiotherapy for rectal cancer management. World Journal of Gastroenterology. 2019 sep 9;25(33): 4850.